banner banner

News Details

Home > News >

Company news about Tirzepatide weight loss

Events
Contact Us
Mr. Will
86-0755-88881688
Contact Now

Tirzepatide weight loss

2025-01-15

Tirzepatide is a dual glucagon-like peptide (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) receptor agonist primarily used to treat type 2 diabetes. Its unique dual mechanism of action makes it show remarkable effects in hypoglycemia and weight management.


       Mechanism of drug action
       Tirzepatide activates both GLP-1 and GIP receptors:

  • GLP-1: Lowers blood sugar by promoting insulin secretion, inhibiting glucagon release, delaying gastric emptying and reducing appetite.
  •  GIP: Enhances insulin secretion sensitivity and works synergistically with GLP-1 to further reduce blood sugar and body weight.
banner
News Details
Home > News >

Company news about-Tirzepatide weight loss

Tirzepatide weight loss

2025-01-15

Tirzepatide is a dual glucagon-like peptide (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP) receptor agonist primarily used to treat type 2 diabetes. Its unique dual mechanism of action makes it show remarkable effects in hypoglycemia and weight management.


       Mechanism of drug action
       Tirzepatide activates both GLP-1 and GIP receptors:

  • GLP-1: Lowers blood sugar by promoting insulin secretion, inhibiting glucagon release, delaying gastric emptying and reducing appetite.
  •  GIP: Enhances insulin secretion sensitivity and works synergistically with GLP-1 to further reduce blood sugar and body weight.